🔗 Share this article

Chancellor Reeves has announced she is planning "specific measures to address household expense pressures" in the forthcoming financial statement.

Speaking to the BBC, she emphasized that lowering inflation is a shared responsibility of both the administration and the central bank.

The United Kingdom's inflation rate is projected to be the highest among the G7 advanced economies this calendar year and next.

Possible Utility Bill Interventions

Sources suggest the administration could take action to bring down utility costs, for example by cutting the present 5% level of value-added tax applied on energy.

Another option is to lower some of the regulatory levies presently added to household expenses.

Fiscal Constraints and Expert Expectations

The administration will receive the latest assessment from the independent fiscal watchdog, the Office for Budget Responsibility, on the start of the week, which will clarify how much space there is for these actions.

The view from the majority of experts is that Reeves will have to introduce higher taxes or budget cuts in order to meet her declared borrowing rules.

Previously on the same day, calculations indicated there was a £22bn deficit for the chancellor to resolve, which is at the lower end of expectations.

"There's a shared responsibility between the central bank and the government to further reduce some of the causes of price increases," the Chancellor informed reporters in Washington, at the yearly gatherings of the IMF and World Bank.

Revenue Pledges and Global Concerns

While much of the focus has been on probable tax increases, the Treasury chief said the most recent information from the OBR had not changed her pledge to campaign commitments not to raise rates on earnings tax, VAT or National Insurance.

She attributed an "uncertain global environment" with increasing international and trade tensions for the fiscal revenue measures, probably to be directed on those "most able to pay."

International Trade Disputes

Referring to concerns about the United Kingdom's commercial links with China she said: "Our security interests invariably are paramount."

Recent announcement by Chinese authorities to increase export controls on critical minerals and other materials that are key for high-technology manufacturing led US President Donald Trump to suggest an additional 100% tariff on imports from China, raising the risk of an all-out commercial conflict between the two largest economies.

The US Treasury Secretary called the Chinese move "economic coercion" and "a global supply chain control attempt."

Asked about considering the US offer to join its battle with the Asian nation, Reeves said she was "deeply worried" by China's actions and urged the Chinese government "to avoid restrictions and limit trade."

She said the action was "damaging for the international commerce and causes additional headwinds."

"In my view there are fields where we need to address Chinese policies, but there are also significant chances to trade with Chinese markets, including banking sector and other sectors of the economy. We've got to achieve that equilibrium right."

The Treasury chief also stated she was working with G7 counterparts "regarding our own critical minerals strategy, so that we are less reliant."

Health Service Medicine Costs and Investment

Reeves also acknowledged that the price the NHS spends on pharmaceuticals could increase as a consequence of current discussions with the US government and its pharmaceutical firms, in exchange for reduced taxes and investment.

Some of the world's largest drug companies have said in recent statements that they are either pausing or abandoning projects in the United Kingdom, with several attributing the modest returns they are receiving.

Last month, the government science advisor said the price the NHS spends on drugs would have to increase to prevent companies and drug research funding departing from the United Kingdom.

The Chancellor told media: "It has been observed as a result of the payment system, that clinical trials, recent pharmaceuticals have not been offered in the United Kingdom in the manner that they are in other continental states."

"We want to guarantee that individuals receiving care from the National Health Service are can obtain the top critical treatments in the world. And so we are examining all of that, and... looking to obtain more investment into Britain."